In two separate articles in the Annals of Neurology , clinicians in India and England report cases of Guillain-Barré syndrome in individuals who received the AstraZeneca COVID-19 vaccine.
Both reports describe an unusual variant of Guillain-Barré syndrome characterised by prominent facial weakness. Seven cases were reported from a regional medical...